Thymogen

Immune Bioregulator (Glu-Trp)

Thymogen (also known as Thymagen) is a synthetic dipeptide (Glu-Trp) developed from thymic tissue research. It supports immune function by enhancing T-cell maturation and modulating immune system signaling.

The Science

What is Thymogen?

Thymogen is a short dipeptide—glutamyl-tryptophan—developed in Russia as a thymic peptide bioregulator that mimics the immunomodulatory action of natural thymic factors.

It supports T-cell differentiation and maturation, helping restore immune balance in conditions of immune suppression or age-related decline.

Used as a peptide bioregulator for immune health, particularly during convalescence, chronic infection, or immunosenescence.

Laboratory Observations

Key Observed Effects of Thymogen

Immune Defense

Supports T-cell function and immune surveillance.

Convalescence

Aids recovery from chronic illness or immune suppression.

Age-Related Decline

Counteracts immunosenescence.

Bioregulator Action

Acts through gene expression rather than receptor agonism.

Mechanism of Action

Thymogen modulates T-cell function through thymic bioregulator pathways.

T-Cell Maturation

Supports differentiation and maturation of T-lymphocytes.

Immune Modulation

Helps balance immune system signaling.

Thymic Support

Mimics natural thymic factors that decline with age.

Research-Only Notice

Thymogen is categorized by the FDA as for research-purposes-only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. The information above summarizes effects observed in laboratory studies to date and is provided strictly for scientific and educational reference.